HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE THERAPY ASSOCIATED WITH OSTEONECROSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
dc.contributor.author | MASSARDO, L | |
dc.contributor.author | JACOBELLI, S | |
dc.contributor.author | LEISSNER, M | |
dc.contributor.author | GONZALEZ, M | |
dc.contributor.author | VILLARROEL, L | |
dc.contributor.author | RIVERO, S | |
dc.date.accessioned | 2025-01-23T19:21:58Z | |
dc.date.available | 2025-01-23T19:21:58Z | |
dc.date.issued | 1992 | |
dc.description.abstract | Osteonecrosis is related to the use of steroids in patients with systemic lupus erythematosus (SLE); its association with the use of 'pulses' of methylprednisolone (PMP) is not clear at present. In a retrospective analysis of 190 patients with SLE we found that 19% of 36 patients treated with PMP had osteonecrosis compared with 6% of 154 patients without that treatment (P < 0.04). Risk factors associated with osteonecrosis were PMP treatment, cushingoid appearance, steroid doses greater-than-or-equal-to 40 mg/day during the first month of treatment, a ratio of steroid dose in grams/year greater-than-or-equal-to 12, hematuria and proteinuria. In a stepwise regression model, when cushingoid appearance was excluded, PMP became the only significant factor (P = 0.045). | |
dc.description.abstract | We conclude that osteonecrosis can be considered a long-term complication of PMP treatment in SLE patients. | |
dc.fuente.origen | WOS | |
dc.identifier.issn | 0961-2033 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/98924 | |
dc.identifier.wosid | WOS:A1992KF96700010 | |
dc.issue.numero | 6 | |
dc.language.iso | en | |
dc.pagina.final | 405 | |
dc.pagina.inicio | 401 | |
dc.revista | Lupus | |
dc.rights | acceso restringido | |
dc.subject | OSTEONECROSIS | |
dc.subject | METHYLPREDNISOLONE | |
dc.subject | SYSTEMIC LUPUS ERYTHEMATOSUS | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE THERAPY ASSOCIATED WITH OSTEONECROSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS | |
dc.type | artículo | |
dc.volumen | 1 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |